Article and Video CATEGORIES
We are excited to bring new and updated information to share through our Bladder Cancer Video Library.
For this video series, we are pleased to work with Dr. Shilpa Gupta, Director of the Genitourinary Medical Oncology at TCI and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic, Dr. Petros Grivas, Oncologist with the Seattle Cancer Care Alliance, UW Medicine and Fred Hutchinson Cancer Research Center, and Dr. Jason Brown, Medical Oncologist at University Hospitals Cleveland Medical Center.
In this video, Dr. Jason Brown examines tumor mutation burden, and explains the role of neoantigens.
A huge thank you to our sponsor! #pfizer
To join the conversation, visit https://cancergrace.org/forums/bladder-cancer.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…